O9 Survival with newly-diagnosed metastatic prostate cancer in the “docetaxel era”: Data from around 700 patients in the control arm of the STAMPEDE trial (NCT00268476)

✍ Scribed by James, N.D.; Clarke, N.W.; Mason, M.D.; Spears, M.R.; Aebersold, D.; Dearnaley, D.P.; De Bono, J.S.; Millman, R.; Parker, C.C.; Parmar, M.K.B.; Ritchie, A.W.S.; Russell, M.; Thalmann, G.N.; Sydes, M.R.

• Book ID: 122116705
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 74 KB
• Volume: 12
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)62329-5